Ectin Research AB (XSAT:ECTIN B) Operating Cash Flow per Share : kr-0.62 (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Operating Cash Flow per Share?

Ectin Research AB's operating cash flow per share for the three months ended in Mar. 2024 was kr-0.15. Ectin Research AB's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.62.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Ectin Research AB's Operating Cash Flow per Share or its related term are showing as below:

XSAT:ECTIN B's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Ectin Research AB Operating Cash Flow per Share Historical Data

The historical data trend for Ectin Research AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Operating Cash Flow per Share Chart

Ectin Research AB Annual Data

Trend

Aug19

Aug20

Dec22

Dec23

Operating Cash Flow per Share

-0.08

-1.06

-0.60

Ectin Research AB Quarterly Data
	Aug19	Aug20	Mar21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial								-0.13	-0.15	-0.16	-0.16	-0.15

Competitive Comparison of Ectin Research AB's Operating Cash Flow per Share

For the Biotechnology subindustry, Ectin Research AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ectin Research AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Ectin Research AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Ectin Research AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-7.591	/	12.690
	=	-0.60

Ectin Research AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-1.918	/	12.690
	=	-0.15

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.62

Ectin Research AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ectin Research AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.ectinresearch.com

Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB Headlines

No Headlines